SPRO
Spero Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD2.80
-0.03 (-1.06%)
Rating:A-
Company Profile
CEO
Esther Rajavelu
IPO Date
2017-11-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$2.85
Prev. Close
$2.83
Day Low
$2.77
Day High
$2.86
52W Low
$1.80
52W High
$3.22
Market Cap
$0.16B
Volume
0.77M